About Beijing Hotgen Biotech Co.,Ltd Company

The company, founded in June 2005, is a high-tech biotechnology enterprise with the mission of “developing biotechnology to benefit human health”. The company continues to explore independent innovative diagnostic technology platforms, actively develop and expand liquid biopsy cancer early screening technology, and establish a multiomics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation; at the same time, it has set up a future technology research institute to explore cutting-edge technology, actively lay out biopharmaceutical fields such as antibody drugs, live bacteria drugs, and exosome drugs, and create a development strategy for the entire industry chain from diagnosis to treatment. The company is a high-tech biotechnology enterprise with the mission of “developing biotechnology to benefit human health”. It closely focuses on innovative biotechnology and lays out solutions from early screening and diagnosis to treatment of diseases. Main products: In vitro diagnostic products, antibody drugs, active bacteria drugs, nucleic acid drugs, etc. Corporate honors: National Technological Invention Award, Rare Earth Science and Technology Award, Independent Innovation Gold Award, etc.